ACTRN12616001474448
Not yet recruiting
未知
Pharmacist involvement to enhance identification and management of patients at discharge from hospital with increased risk of medication related problems and effect on quality of life and readmission to hospital: a double arm, randomised clinical trial.
Health Research South0 sites700 target enrollmentOctober 24, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Readmission to hospital
- Sponsor
- Health Research South
- Enrollment
- 700
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Eligible participants are adult (over 18 years) patients being treated on the Internal Medicine ward at Dunedin Hospital who are identified as being high risk for readmission by an electronic prioritisation tool. Patients meet inclusion criteria if they are allocated a certain score using a prioritisation tool on admission. The cut off score for inclusion is still to be decided (the electronic tool validation is underway currently).
Exclusion Criteria
- •Patients who don't meet a certain score by the electronic prioritization tool (that identifies those at high risk for readmission) will be excluded from the study. Those who are unable to provide informed consent will be excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Development of intervention tool and its effect on health care of patients with dyslipidemia by community pharmacistsDyslipidemiaJPRN-UMIN000044945Showa University40
Terminated
Not Applicable
Enhancing Pharmacist Involvement in Care - Medication Assisted Treatment for Opioid Dependence (EPIC-MATOD) Implementation StudyOpioid dependencePublic Health - Health service researchMental Health - AddictionACTRN12621000871842Monash University85
Not yet recruiting
Phase 1
The role of pharmacist for enhancing medication adherence in COPD (Chronic Obstructive Pulmonary Diseases) patients in pakistaChronic Obstructive Pulmonary Disease (COPD).Chronic obstructive pulmonary disease, unspecifiedJ44.9IRCT20220516054875N1Quaid-i-Azam University , Islamabad150
Not yet recruiting
Not Applicable
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45
Completed
Not Applicable
Influence investigation by the pharmacist follow after the medicatioDiabetesJPRN-UMIN000042922others Chiba Pharmaceutical Association37